resumo Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.msard.2019.101860.
autores Neves NM Ana Gabriela S. Oliveira Goncalves, Margarida Ferreira, H. M. Neves, N. Neves, N. M.
palavras-chave Adverse events Expanded disability status scale Mesenchymal stem cells Multiple sclerosis Therapeutic efficacy